Showing results (1-10 of 237) with videos related to
Sort By:
Pageof 24
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 11, 2008
[Development trend in new therapeutic approaches for anemia]Kazuma OhyashikiLeukemia & Lymphoma|May 29, 2003
Immunosuppressive treatments for myelodysplastic syndromesTakashi Shimamoto, Kazuma OhyashikiNihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Role of bortezomib in the treatment of multiple myeloma]Akihiko Gotoh, Kazuma OhyashikiInternational Journal of Hematology|June 8, 2006
The second generation of BCR-ABL tyrosine kinase inhibitorsTetsuzo Tauchi, Kazuma OhyashikiGan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2003
[Molecular-target therapy of Ph-positive leukemia by imatinib (tyrosine kinase inhibitor)]Tetsuzo Tauchi, Kazuma OhyashikiNihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Hematopoietic cell death and leukemia]Tomohisa Yokoyama, Kazuma OhyashikiLeukemia Research|March 24, 2004
Molecular mechanisms of resistance of leukemia to imatinib mesylateTetsuzo Tauchi, Kazuma OhyashikiInternational Journal of Hematology|July 9, 2004
Imatinib mesylate in combination with other chemotherapeutic agents for chronic myelogenous leukemiaTetsuzo Tauchi, Kazuma OhyashikiClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cellsSeiichi Okabe, Tetsuzo Tauchi, Kazuma Ohyashiki[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 20, 2009
[Molecular relapse of chronic myeloid leukemia after discontinuation of imatinib mesylate for maintaining complete molecular response for more than 2 years]Toru Kiguchi, Tetsuzo Tauchi, Kazuma OhyashikiPageof 24